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ABSTRACT 
Solar UV radiation damages human skin, affecting skin 
tone and resiliency and leading to premature aging (pho- 
toaging), the symptoms of which include leathery texture, 
wrinkles, mottled pigmentation, laxity and sallowness. 
We propose that photoaging results largely from UV in- 
duction of matrix metalloproteinases (MMP) that de- 
grade skin collagen. We find that pretreatment of human 
skin with all-trans retinoic acid ( tRA)  inhibits UV induc- 
tion of MMP, suggesting that tRA can protect against 
UV-induced collagen destruction and may therefore be 
able to lessen the effects of photoaging. The tRA prevents 
UV-induced accumulation of c-Jun protein, which is re- 
quired for MMP gene expression. Activation of c J u n  
transcriptional activity requires N-terminal phosphory- 
lation. The majority of c-Jun in human skin in vivo is N- 
terminal phosphorylated. Topically applied tRA does not 
inhibit N-terminal phosphorylation by UV-induced cJun 
kinase activity in human skin. The tRA likely acts to re- 
duce UV induction of c-Jun protein by stimulating its 
breakdown through the ubiquitin-proteasome pathway. 
INTRODUCTION 
Solar UV radiation damages human skin cells, affecting skin 
tone and resiliency and leading to premature aging (photo- 
aging), the symptoms of which include leathery texture. 
wrinkles, mottled pigmentation. laxity and sallowness ( 1  ). 
We further define photoaged skin by the presence of elevated 
matrix metalloproteinases (MMP)t that degrade collagen 
and appear long before the visible symptoms of photoaging. 
We have investigated the molecular mechanisms by which 
UV damages collagen in the dermal extracellular matrix. In 
contrast to the prevailing clinical approach to photoaging 
that focuses on treating symptoms after they have become 
clinically apparent, we advocate a preventive approach to 
treatment of photoaging of human skin before the appear- 
ance of clinical symptoms. We review evidence that topi- 
cally applied all-trans retinoic acid (rRA), which is known 
to stimulate repair of photoaged skin (2), also protects 
against UV-induced collagen destruction and may therefore 
be able to lessen the effects of photoaging. Topical appli- 
cation of rRA to skin at least 16 h prior to exposure effec- 
tively reduces induction of MMP. 
We have proposed a working model for the pathophysi- 
ology of photoaging based on prior experiments that have 
studied molecular responses of human skin to a single UV 
exposure (3). According to this model, UV activates growth 
factor and cytokine receptors on keratinocytes and fibro- 
blasts. resulting in downstream signal transduction through 
activation of mitogen-activated protein (MAP) kinase path- 
ways. These signaling pathways converge in the nucleus of 
cells to induce c-Jun, which heterodimerizes with constitu- 
tively expressed c-Fos to form activated complexes of the 
transcription factor AP-1. In the dermis and epidermis, AP-1 
induces expression of MMP collagenase, 92 kDa gelatinase 
and stromelysin. which degrade collagen and other proteins 
that comprise the dermal extracellular matrix. We believe 
that dermal breakdown is followed by imperfect repair that 
yields a deficit in the structural integrity of the dermis, a 
solar scar. Over time, intermittent exposure to UV leads to 
an accumulation of solar scars that eventually manifest as 
wrinkled, photoaged skin. All-trans retinoic acid acts to in- 
hibit induction of c-Jun protein by UV, preventing increased 
MMP and ensuing dermal damage. 
MATERIALS AND METHODS 
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UV irnrtlictrion mid tissrte procrrrurnrnt. Healthy adult Caucasians, 
with light to mild pigmentation, were irradiated with fluorescent 
UVB lights, as previously described (4). Wavelengths below 290 
nm were removed by a Kodacel TA401/407 sheet. The UV dose 
that caused barely perceptible skin reddening (minimal erythema 
dose. MED) was determined for each subject, 24 h aftcr irradiation. 
Irradiated and nonirradiated skin samples were obtained from each 
subject by keratome or punch hiopsy, as described ( 5 ) .  The fRA 
(Sigma Chemical Company) and its vehicle ( 7 0 8  ethanol. 30% po- 
lyethyleneglycol. O.OS9k butylated hydroxytoluenc) were applied to 
skin under occlusion. 48 h prior to UV treatment. All procedures 
154 
Photochemistry and Photobiology, 1999, 69(2) 155 
involving human subjects were approved by the University of Mich- 
igan Institutional Review Board, and all subjects provided written 
infonned consent. 
Preparation of skin supernatorits for biochemical anaf.yses. Skin 
samples were ground by mortar and pestle under liquid nitrogen and 
homogenized in a Dounce tissue grinder in buffer containing 10 mM 
HEPES, 1 mM EDTA, 5 mM EGTA, 10 mM MgCI2, 50 mM glyc- 
erophosphate, 5 mM NaVO,, 2 mM dithiothreitol (DTT), 0.5 mM 
phenylmethylsulfonyl fluoride (PMSF), 10 pg/mL aprotinin, 10 )*g/ 
mL leupeptin, 10 )*g/mL pepstatin and 0.5% Nonidet P-40. Homog- 
enates were centrifuged at 14000 g for 15 min, supernatants col- 
lected and used for biochemical determinations described below. 
c-Jun kiriasr ( J N K )  assay. The INK activity in skin supernatants 
was determined by solid-phase kinase assay, as described (6); JNK 
was immunoprecipitated with antibodies from Santa Cru7 Biotech- 
nology and assayed for activity using glutathione S-transferase-c- 
Jun as substrate. 
Preparation of nuclecir extracts froin human skin. Individual ker- 
atome biopsies were placed in 0.25% trypsin. 0.1% EDTA for 40 
min at 37°C. Skin samples were trypsinized and cells were released 
from the tissue by scraping. Released cells were washed three times 
in phosphate-buffered saline, and resuspended in 20 mM Tris (pH 
8.0). 20 mM NaCl, 6 mM MgCI?. 0.2% Triton X-100. 1 mM DTT, 
200 mM sucrose, I mM PMSF, 0.02 mg/mL leupeptin, 0.02 mg/mL 
pepstatin A, at a concentration of 2 X lo7 cells/inL (7). Nuclear 
extracts containing c-Jun were prepared as described previously (8). 
Extracts were aliquoted and stored at -70°C prior to use. 
Western anufwis of cJun .  The c-Jun protein (antibody from 
Transduction Laboratories) and phosphorylated c-Jun (antibody 
from New England BioLabs) were detected in nuclear extracts from 
human skin by western analysis, as described (7). 
RESULTS AND DISCUSSION 
UV triggers MAP kinase signal transduction 
pathways in human skin in vivo 
Cellular physiology is largely regulated by hormones, 
growth factors and cytokines acting through their respective 
cell surface receptors. One of the earliest effects of UV is 
activation of cell surface receptors (9). It appears likely that 
UV activates most, if not all, growth factor and cytokine 
receptors. We examined activation of the epidermal growth 
factor (EGF) receptor by UV in human skin. Activation of 
the EGF receptor, as demonstrated by autophosphorylation 
of specific tyrosine residues, occurs within 15 min of UV 
irradiation (2 MED) and remains elevated for at least 2 h 
(10). 
Activation of growth factor and cytokine receptors results 
in assembly of protein complexes that transduce signals from 
the cell surface to the nucleus. When these complexes as- 
semble, small, GTP-binding regulatory proteins are activat- 
ed, including Ras and Rac, that function as molecular 
switches to trigger MAP kinase signal transduction path- 
ways. In human skin, Ras is activated within 30 min of UV 
exposure and remains activated for at least 24 h (10). Acti- 
vated Rac directly stimulates the NADPH oxidase enzyme 
complex in cells, increasing levels of two reactive oxygen 
species, superoxide anion and hydrogen peroxide that are 
critical for MAP kinase-mediated signal transduction. 
Ultraviolet irradiation activates each of the three MAP 
kinases, ERK, JNK and p38, through dual phosphorylation 
of threonine and tyrosine. The ERK, JNK and p38 are ac- 
tivated within 1 h of UV irradiation, maximally activated 4 
h post-UV and return to baseline within 24 h after UV ex- 
posure (10). 
UV exposure induces c-Jun and activates AP-1 in human 
skin in vivo 
Activation of ERK, JNK and p38 MAP kinases results in 
increased expression of the transcription factors c-Fos and 
c-Jun in cultured cells. The c-Fos and c-Jun form stable het- 
erodimers, and, together with other protein factors, form the 
transcription factor AP-1. The AP-1 regulates the genes for 
several members of the MMP family (1 1). In nonirradiated 
human skin, c-Jun mRNA and protein levels are minimally 
detectable, while c-Fos mRNA and protein are readily de- 
tectable. Ultraviolet rapidly induces c-Jun mRNA and pro- 
tein, but c-Fos protein is not affected (10). Our findings in- 
dicate that AP-1 activation by UV is primarily dependent on 
induction of c-Jun, because c-Fos is constitutively expressed 
in human skin in viva 
This conclusion is further supported by measurement of 
AP-1 complexes and by gel shift analyses in nonirradiated 
and UV-irradiated human skin. In nonirradiated human skin, 
AP-1 complexes contain predominantly c-Fos and Jun D, 
which, like c-Fos, is constitutively expressed and not in- 
duced by UV irradiation (10). Following UV irradiation, AP- 
1 levels are increased and AP-1 complexes are enriched in 
c-Jun, relative to nonirradiated human skin. These findings 
indicate that UV-induced c-Jun forms functional complexes 
with constitutively expressed c-Fos (10). The UV activation 
of AP-I, measured by gel shift analyses, is induced at very 
low levels of UV (0.1-1 MED). Taken together, these results 
indicate that UV induces increases in activated AP-1 com- 
plexes, composed of c-Jun and c-Fos, in human skin in vivo. 
Activated AP- 1 would be expected to stimulate transcription 
of MMP target genes. 
UV irradiation induces MMP that degrade the dermal 
extracellular matrix in human skin in vivo 
The MMP are a family of zinc-requiring enzymes that spe- 
cifically break down proteins that comprise connective tis- 
sue. The AP- 1 strongly regulates transcription of at least four 
members of the MMP family, collagenase (that cleaves fi- 
brillar types I and I11 collagens), 92 kDa gelatinase (that 
further breaks down collagen subsequent to collagenase 
cleavage, and also degrades type IV collagen and elastin), 
stromelysin (that degrades type IV collagen, elastin and oth- 
er extracellular matrix molecules, including proteoglycans 
and laminins) and metalloelastase (that cleaves elastin fibers) 
(1 1). Ultraviolet induces expression of these MMP genes in 
human skin in vivo, consistent with UV activation of AP-1. 
Collagenase, 92 kDa gelatinase and stromelysin mRNA lev- 
els are increased following UV irradiation and remain ele- 
vated for more than 24 h (4). These data are consistent with 
the notion that UV activation of AP- 1 drives MMP induction 
in human skin in vivo. 
Sun damage to the extracellular matrix of the dermis be- 
comes histologically and clinically observable only after it 
accumulates with multiple sun exposures (1). A single UV 
exposure causes acute induction of MMP, which return to 
basal levels within 48-72 h after exposure. If MMP induc- 
tion by UV is responsible for dermal damage in photoaging, 
then MMP induction would be expected to remain respon- 
sive to multiple UV exposures. To test this hypothesis, sub- 
jects were irradiated multiple times at 48 h intervals over a 
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7 day period. As expected, collagenase and 92 kDa gelati- 
nase were maximally induced following a single exposure 
to UV. With every-other-day exposure to UV, these maximal 
levels were maintained for 7 days. suggesting that there is 
no attenuation of MMP induction with repeated exposures 
In order for UV-induced MMP to cause the dermal dam- 
age known as photoaging, they must be localized in the der- 
mis. We utilized in sitri hybridization. immunohistology and 
in sitii zymography to localize expression and activity of 
MMP in nonirradiated and UV-irradiated human skin. While 
mRNA, proteins and activities of collagenase, 92 kDa ge- 
latinase and stromelysin were minimally detectable in non- 
irradiated human skin with these techniques, mRNA and ac- 
tivities of these MMP were readily detectable following ex- 
posure to UV. Collagenase, 92 kDa gelatinase and strome- 
lysin mRNA were induced throughout all of the layers of 
the epidermis. hut only collagenase and stromelysin mRNA 
were induced in  dermal cells. Activities of these MMP were 
also found i n  the deimis. Together, these data indicated that 
collagenase, 93 kDa gelatinase and stromelysin proteins are 
substantially elevated and active in the dermis and epidermis 
of human skin following UV irradiation ( 3 ) .  
Together, collagenase. 92 kDa gelatinase and stromelysin 
have the capacity to degrade all of the protein components 
of the dermal extracellular matrix. To obtain direct evidence 
for collagen breakdown following acute UV exposure, we 
quantitated soluble breakdown products of type I fibrillar 
collagen in nonirradiated and UV-irradiated human skin by 
radioimmunoassay. Results indicated that the MMP induced 
by UV irradiation and localized in the dermis degrade en- 
dogenous fihrillar collagen in human skin in v i i v  (3). 
In addition to inducing AP- I-regulated MMP. UV irradi- 
ation induces an endogenous MMP inhibitor, TIMP-I ( 3 ) .  
The TIMP-1 mRNA and protein are induced with similar 
kinetics and UV dose dependence as the MMP. This coin- 
duction of MMP and TIMP-I acts to inhibit MMP activity 
and thereby prevent excessive connective tissue break down 
(17). Data presented above, however, indicate that UV-in- 
duced MMP activities exceed the inhibitory capacity of 
TIMP- I ,  and therefore some dermal extracellular matrix de- 
struction occurs. 
(3). 
tRA pretreatment inhibits UV induction of MMP by 
inhibiting UV induction of cJun protein in human 
skin in vivo 
Because UV induces AP- I ,  which stimulates expression of 
MMP that degrade collagen in the dermis of human skin in 
vivo, preventive agents must block induction at some point 
along the signal transduction pathway. In cultured cells, rRA 
antagonizes AP- I through a mechanism known as “trans- 
repression” that is mediated by nuclear retinoic acid recep- 
tors (RAR) (13). Evidence suggests that transrepression of 
AP- 1 by tRA-activated RAR results from binding of protein 
factors required for  AP-I activity to activated RAR. We 
therefore examined the effects of fRA on UV induction of 
MMP in human skin in vivo. Pretreatment of skin with tRA 
significantly inhihited UV induction of collagenase, 92 kDa 
gelatinase and stromelysin mRNA (50-60%,) and proteins 
(60-80%) (4). 
Figure 1. The c-Jun in human skin it1 vivo. whether exposed to UV 
or rRA. exists in a predominantly N-terminal phosphoiylated state. 
Human buttock skin was pretreated with vehicle ( V )  or  0.15% fRA 
( R A )  for 48 h prior to irradiation with 2 MED UVB (UV). Biopsies 
were taken 8 h later and nuclear extracts were prepared and analyzed 
for c-Jun protein levels by western blot analysis using an antibody 
against total c-Jun. Lanes 1 and 2 show recombinant nonphosphor- 
ylated and N-tenninal phosphorylated c-Jun standards, respectively. 
Western blots of nuclear extracts prepared from two different indi- 
viduals that are representative of six different subjects are shown. 
The rRA inhibited UV-induced MMP activities through- 
out the epidermis and dermis, as demonstrated both by im- 
munohistology and in situ zymography (3). Interestingly, 
rRA did not inhibit UV induction of TIMP-1 (3). Therefore, 
rRA pretreatment increased the ratio of TIMP-I to MMP in 
human skin following UV irradiation. Elevated TIMP- 1 
would effectively inhibit most, if not all, of the residual 
MMP activities induced by UV in rRA-pretreated skin. This 
relative TIMP-1 excess may explain why tRA pretreatment 
appears to inhibit UV induction of MMP activities complete- 
ly, as measured by in situ zymography. These data raise the 
possibility that rRA, which has previously been shown to 
improve the appearance of photodamaged skin, may also 
prevent photodamage. 
Because UV induction of AP-1 appears to be critical for 
increased MMP expression, we examined the effect of tRA 
on AP-1 levels. Pretreatment of human skin with rRA for 48 
h resulted in 70% inhibition of UV-induced AP-1 DNA 
binding. In marked contrast, 8 h of tRA pretreatment had no 
effect on UV-induced AP-I DNA binding (10). 
We next examined the effect of tRA pretreatment on lev- 
els of c-Fos and c-Jun in nonirradiated and UV-irradiated 
human skin. Pretreatment with fRA for 48 h did not alter the 
levels of c-Fos mRNA or c-Jun mRNA or protein in nonir- 
radiated human skin. or c-Fos mRNA or protein levels in 
UV-irradiated skin. As stated earlier, UV induces c-Jun 
mRNA and protein. Pretreatment with IRA for 48 h did not 
inhibit UV induction of c-Jun mRNA but did inhibit UV 
induction of c-Jun protein by 70% throughout the epidermis 
and dermis. Eight hours of tRA pretreatment did not inhibit 
UV induction of c-Jun protein (10). Taken together, these 
data suggest a mechanism whereby tRA, acting through its 
nuclear receptors, induces expression of an inhibitor of c- 
Jun protein translation or an activator of c-Jun degradation. 
Recent evidence indicates that the ubiquitin proteasome 
pathway represents a major route for c-Jun degradation. The 
N-terminal phosphorylation of c-Jun by JNK inhibits c-Jun 
ubiquitination and thereby prolongs the half-life of c-Jun 
(14). In nontreated and UV-irradiated human skin. the ma- 
jority of c-Jun is N-terminal phosphorylated (Fig. 1). The 
majority of c-Jun in human skin treated with tRA alone or 
tRA plus UV irradiation is also N-terminal phosphorylated 
(Fig. 1 )  Thus, whether c-Jun is present in low basal levels 
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inappropriate activation of cell surface receptors, signal 
transduction pathways, transcription factors and MMP occur 
in a variety of pathological conditions characterized by hy- 
perproliferation, malignant transformation, inflammation and 
connective tissue damage. 
s 2o 1 
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